The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, T.-F.
Right arrow Articles by Reich, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, T.-F.
Right arrow Articles by Reich, N. C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2006, 176: 7462-7470.
Copyright © 2006 by The American Association of Immunologists

Differential Activation of IFN Regulatory Factor (IRF)-3 and IRF-5 Transcription Factors during Viral Infection1

Tsu-Fan Cheng, Sabrina Brzostek, Osamu Ando2, Sarah Van Scoy, K. Prasanna Kumar3 and Nancy C. Reich4

Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794

Members of the IFN regulatory factor (IRF) family regulate gene expression critical to immune response, hemopoiesis, and proliferation. Although related by homology at their N-terminal DNA-binding domain, they display individual functional properties. The distinct properties result from differences in regulated expression, response to activating signals, and interaction with DNA regulatory elements. IRF-3 is expressed ubiquitously and is activated by serine phosphorylation in response to viral infection or TLR signaling. Evidence indicates that the kinases TANK-binding kinase 1 and inhibitor of NF-{kappa}B kinase-{epsilon} specifically phosphorylate and thereby activate IRF-3. We evaluated the contribution of another member of the IRF family, IRF-5, during viral infection since prior studies provided varied results. Analysis of phosphorylation, nuclear translocation, dimerization, binding to CREB-binding protein, recognition of DNA, and induction of gene expression were used comparatively with IRF-3 as a measure of IRF-5 activation. IRF-5 was not activated by viral infection; however, expression of TANK-binding kinase 1 or inhibitor of NF-{kappa}B kinase-{epsilon} did provide clear activation of IRF-5. IRF-5 is therefore distinct in its activation profile from IRF-3. However, similar to the biological effects of IRF-3 activation, a constitutively active mutation of IRF-5 promoted apoptosis. The apoptosis was inhibited by expression of Bcl-xL but not a dominant-negative mutation of the Fas-associated death domain. These studies support the distinct activation profiles of IRF-3 in comparison to IRF-5, but reveal a potential shared biological effect.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. Wies, A. S. Hahn, K. Schmidt, C. Viebahn, N. Rohland, A. Lux, T. Schellhorn, A. Holzer, J. U. Jung, and F. Neipel
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5
J. Biol. Chem., March 27, 2009; 284(13): 8525 - 8538.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Y. Balkhi, K. A. Fitzgerald, and P. M. Pitha
Functional Regulation of MyD88-Activated Interferon Regulatory Factor 5 by K63-Linked Polyubiquitination
Mol. Cell. Biol., December 15, 2008; 28(24): 7296 - 7308.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Paun, J. T. Reinert, Z. Jiang, C. Medin, M. Y. Balkhi, K. A. Fitzgerald, and P. M. Pitha
Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response
J. Biol. Chem., May 23, 2008; 283(21): 14295 - 14308.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Q. Li, L. Tang, P. C. Roberts, J. M. Kraniak, A. L. Fridman, O. I. Kulaeva, O. S. Tehrani, and M. A. Tainsky
Interferon Regulatory Factors IRF5 and IRF7 Inhibit Growth and Induce Senescence in Immortal Li-Fraumeni Fibroblasts
Mol. Cancer Res., May 1, 2008; 6(5): 770 - 784.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. Dideberg, G. Kristjansdottir, L. Milani, C. Libioulle, S. Sigurdsson, E. Louis, A.-C. Wiman, S. Vermeire, P. Rutgeerts, J. Belaiche, et al.
An insertion deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases
Hum. Mol. Genet., December 15, 2007; 16(24): 3008 - 3016.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. J. Martin, J. M. Lee, D. Walls, and S. D. Hayward
Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus
J. Virol., September 15, 2007; 81(18): 9748 - 9758.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Barro and J. T. Patton
Rotavirus NSP1 Inhibits Expression of Type I Interferon by Antagonizing the Function of Interferon Regulatory Factors IRF3, IRF5, and IRF7
J. Virol., May 1, 2007; 81(9): 4473 - 4481.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Yanai, H.-m. Chen, T. Inuzuka, S. Kondo, T. W. Mak, A. Takaoka, K. Honda, and T. Taniguchi
Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression
PNAS, February 27, 2007; 104(9): 3402 - 3407.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.